Jose S. Gil, Ph.D. - Publications

Affiliations: 
2008 University of California, Los Angeles, Los Angeles, CA 
Area:
Molecular Biology, Virology Biology

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Zaiss AK, Zuber J, Chu C, Machado HB, Jiao J, Catapang AB, Ishikawa TO, Gil JS, Lowe SW, Herschman HR. Reversible suppression of cyclooxygenase 2 (COX-2) expression in vivo by inducible RNA interference. Plos One. 9: e101263. PMID 24988319 DOI: 10.1371/Journal.Pone.0101263  0.606
2013 Gil JS, Machado HB, Campbell DO, McCracken M, Radu C, Witte ON, Herschman HR. Application of a rapid, simple, and accurate adenovirus-based method to compare PET reporter gene/PET reporter probe systems. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 15: 273-81. PMID 23054556 DOI: 10.1007/S11307-012-0596-5  0.545
2012 Gil JS, Machado HB, Herschman HR. A method to rapidly and accurately compare the relative efficacies of non-invasive imaging reporter genes in a mouse model and its application to luciferase reporters. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 14: 462-71. PMID 21850545 DOI: 10.1007/S11307-011-0515-1  0.628
2010 Gil JS, Gallaher SD, Berk AJ. Delivery of an EBV episome by a self-circularizing helper-dependent adenovirus: long-term transgene expression in immunocompetent mice. Gene Therapy. 17: 1288-93. PMID 20463755 DOI: 10.1038/Gt.2010.75  0.809
2009 Gallaher SD, Gil JS, Dorigo O, Berk AJ. Robust in vivo transduction of a genetically stable Epstein-Barr virus episome to hepatocytes in mice by a hybrid viral vector. Journal of Virology. 83: 3249-57. PMID 19158239 DOI: 10.1128/Jvi.01721-08  0.804
2006 Schwarz J, Schwarz SC, Dorigo O, Stützer A, Wegner F, Labarca C, Deshpande P, Gil JS, Berk AJ, Lester HA. Enhanced expression of hypersensitive alpha4* nAChR in adult mice increases the loss of midbrain dopaminergic neurons. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 935-46. PMID 16675851 DOI: 10.1096/Fj.05-5497Com  0.753
2006 Gil JS, Gallaher SD, Berk AJ. 848. Helper Dependent Adenovirus-Epstein- Barr Virus Hybrid Vector for Long Term Persistance in Hepatocytes Molecular Therapy. 13: S327. DOI: 10.1016/J.Ymthe.2006.08.934  0.815
2006 Gallaher SD, Gil JS, Berk AJ. 14. High Efficiency and Long-Term Persistence In Vivo from a Helper Dependent Adenovirus/Epstein-Barr Virus Hybrid Vector Molecular Therapy. 13: S6. DOI: 10.1016/J.Ymthe.2006.08.025  0.831
2005 Yue Q, Groszer M, Gil JS, Berk AJ, Messing A, Wu H, Liu X. PTEN deletion in Bergmann glia leads to premature differentiation and affects laminar organization. Development (Cambridge, England). 132: 3281-91. PMID 15944184 DOI: 10.1242/Dev.01891  0.638
2005 Gil JS, Gallaher SD, Dorigo O, Berk AJ. 890. Development of a Single Vector System for Gene Delivery Via Hybrid Helper Dependent Adenovirus - Epstein-Barr Virus Vector for Long Term Persistance Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.433  0.794
2005 Gallaher SD, Gil JS, Dorigo O, Berk AJ. 874. Long-Term Transgene Expression In Vivo from a Helper Dependent Adenovirus|[mdash]|Epstein-Barr Virus Hybrid Vector Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.417  0.811
2004 Dorigo O, Gil JS, Gallaher SD, Tan BT, Castro MG, Lowenstein PR, Calos MP, Berk AJ. Development of a novel helper-dependent adenovirus-Epstein-Barr virus hybrid system for the stable transformation of mammalian cells. Journal of Virology. 78: 6556-66. PMID 15163748 DOI: 10.1128/Jvi.78.12.6556-6566.2004  0.802
2004 Gallaher SD, Gil JS, Dorigo O, Berk AJ. 773. Non-Invasive In Vivo Detection of Episomes Delivered to Mouse Hepatocytes by a Helper Dependent Adenovirus- Epstein-Barr Virus Hybrid Vector System Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.697  0.807
Show low-probability matches.